Covista Inc. (ATGE) Stock Analysis and Metrics

Sector: Consumer Defensive Industry: Education & Training Services CIK: 0000730464

ROIC (Qtr) 0.04

Total Debt (Qtr) 504.28 Mn

Revenue Growth (1y) (Qtr) 12.43

Add ratio to table...

About

Adtalem Global Education Inc., a leading healthcare educator in the United States, trades under the ticker symbol ATGE and operates in the healthcare and education industries. The company's main business activities involve providing high-quality education and training to healthcare professionals, with operations in multiple countries and regions. Adtalem's institutions offer a range of programs, including undergraduate and graduate degrees as well as certificate programs, in fields such as nursing, medicine, and veterinary medicine. The company's...

Adtalem Global Education Inc., a leading healthcare educator in the United States, trades under the ticker symbol ATGE and operates in the healthcare and education industries. The company's main business activities involve providing high-quality education and training to healthcare professionals, with operations in multiple countries and regions.

Adtalem's institutions offer a range of programs, including undergraduate and graduate degrees as well as certificate programs, in fields such as nursing, medicine, and veterinary medicine. The company's institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. Each institution offers a unique set of programs and courses tailored to the needs of its students.

Chamberlain University, founded in 1889, offers degree and certificate programs in nursing and health professions. Its nursing degree offerings include a three-year onsite and online pre-licensure Bachelor of Science in Nursing (BSN) degree, an online post-licensure BSN degree completion option for Registered Nurses (RN-BSN), an online Master of Science in Nursing (MSN) degree, and the online Doctor of Nursing Practice (DNP) degree. Chamberlain's College of Health Professions also offers an online Master of Public Health (MPH) degree program, an online Master of Social Work (MSW) degree program, and an onsite Master of Physician Assistant Studies (MPAS) degree program.

Walden University, founded in 1970, provides an engaging learning experience for working professionals. Its programs are enriched by the cultural, economic, and educational backgrounds of its students and instructors. Walden offers over 100 degree and certificate programs, including programs at the bachelor's, master's, education specialist, and doctoral levels, with over 350 specializations and concentrations.

The Medical and Veterinary segment of Adtalem offers degree and certificate programs in medical and veterinary postsecondary education. American University of the Caribbean School of Medicine, founded in 1978, provides medical education and confers the Doctor of Medicine degree. Ross University School of Medicine, also founded in 1978, provides medical education and confers the Doctor of Medicine degree. Ross University School of Veterinary Medicine, founded in 1982, provides veterinary education and confers the Doctor of Veterinary Medicine degree.

Adtalem competes in various markets, including the U.S. nursing education market, which has more than 2,000 programs leading to RN licensure, and the fully online higher education market, which is a growing space. The company competes with U.S. schools of medicine, U.S. colleges of osteopathic medicine, and Caribbean medical schools, as well as with international medical schools recruiting U.S. students who may be eligible to receive funding from ED Title IV programs.

Adtalem's institutions are accredited by various accrediting bodies, including the Higher Learning Commission, the Commission on Collegiate Nursing Education, the Council on Education for Public Health, and the Accreditation Review Commission on Education for the Physician Assistant. Adtalem is an accredited provider of nursing continuing professional development credits by the American Nursing Credentialing Center.

Adtalem's customers include students, healthcare organizations, and government agencies. The company's institutions have an alumni community of over 300,000 and enroll more than 80,000 students learning at multiple campuses and online. The company's position within the industry is strong, with a long history of providing high-quality education and training to healthcare professionals. Adtalem's competitors include other healthcare education providers, such as Kaplan University and DeVry University.

Adtalem's financial performance is affected by various factors, including changes in government funding for education, competition from other healthcare education providers, and the company's ability to attract and retain students. The company's financial statements are audited annually by an independent auditor and are subject to review by the Securities and Exchange Commission.

Adtalem Global Education Inc. provides high-quality education and training to healthcare professionals through its five institutions. Its programs are designed to prepare students for careers in the healthcare industry, and the company has a strong reputation for producing well-trained and highly skilled professionals. The company's institutions are accredited by reputable accrediting bodies and are authorized to operate in multiple states. Adtalem's position within the industry is strong, with a long history of providing high-quality education and training to healthcare professionals. The company's financial performance is affected by various factors, including changes in government funding for education, competition from other healthcare education providers, and the company's ability to attract and retain students.

Investment thesis

Bull case

The latest quarter shows an 8.4% core revenue increase when the one‑week academic calendar shift is excluded, suggesting that the underlying demand for healthcare education remains robust and is not a one‑off timing effect. Four distinct segments—Walden, Chamberlain, Medical and Veterinary—each contributed to revenue growth, but Walden alone delivered a 16.5% rise, driven by record enrollment in both health and non‑health programs. Walden’s operating leverage is evident in its adjusted EBITDA margin expanding from 28.4% to 39.8% after accounting for the calendar shift, reflecting efficient scaling of digital platforms and streamlined student support. The company’s ability to generate $428 million in trailing twelve‑month operating cash flow, up $146 million from the prior year, provides a strong buffer for future capital deployment and debt reduction, which can sustain the current share repurchase pace. The disciplined capital allocation plan, now authorizing $728 million remaining under a $750 million program, indicates management’s confidence in long‑term value creation and offers upside if market perception underestimates the company’s free cash flow generation. The forthcoming Investor Day is positioned as a catalyst; if the announced multi‑year capacity expansion and new revenue streams materialize as projected, it could shift the growth narrative toward a higher revenue guidance range and further justify the share repurchase activity. In addition, the rebrand to Covista, coupled with an explicit positioning as America’s largest healthcare educator, may unlock new strategic partnerships with health systems seeking comprehensive workforce solutions, potentially expanding the pipeline of graduate students beyond traditional modalities. Finally, the company’s philanthropic initiative, Covista Open Doors, aligns with the broader industry focus on workforce sustainability, reinforcing its brand equity among employers and potentially driving employer‑direct recruitment and program enrollment, which could translate into higher tuition revenues over the medium term.
The company’s enrollment trajectory—six consecutive quarters of growth—has recently accelerated in the Walden segment, with a 13% increase in total enrollment, indicating strong demand from working adults and career changers who benefit from flexible online modalities. Walden’s new programs in behavioral science and clinical psychology already attract over 1,000 students in less than a year, suggesting that program diversification is resonating with market needs and can create higher fee‑intensity opportunities. The addition of a PhD completion track for students who left their original program provides a unique, high‑margin product that can attract a niche segment willing to pay premium tuition, thereby enhancing the overall student revenue mix. Walden’s operating margin expansion of 29.4 basis points per quarter beyond the calendar shift illustrates that the company is capitalizing on cost efficiencies in content delivery and administrative overhead, thereby improving profitability even as enrollment scales. The company’s AI‑enabled learning pathways, announced as a focus area, can improve student outcomes and accelerate credential completion, thereby reducing time‑to‑degree and increasing revenue velocity. These digital capabilities also reduce the need for physical infrastructure, which aligns with the company’s capacity expansion strategy while keeping capital expenditures in check. As the healthcare workforce shortage deepens, the demand for accelerated and tech‑enabled pathways will likely increase, creating a favorable tailwind for the company’s enrollment and revenue growth prospects.
The medical and veterinary segment, while smaller, shows a healthy 6.9% revenue growth and a 17.6% increase in adjusted EBITDA, suggesting that the company is successfully leveraging its unique clinical partner network to attract students. The segment’s consistent operating margin around 30% demonstrates disciplined cost management, particularly in the utilization of AI for basic science curricula, which can lower faculty costs and improve pass rates for licensing exams. The company's partnership with the national health systems, highlighted in the news coverage, provides a pipeline of future students who may be recruited through employer‑direct agreements, thereby reducing marketing spend and improving enrollment conversion rates. The sector’s high alumni engagement, evidenced by 700 alumni in C‑suite roles and 300 chief nursing officers, can be leveraged for networking and placement opportunities that enhance the institution’s reputation, leading to a virtuous cycle of demand. The company’s focus on high‑volume programs—MD, nursing, veterinary—positions it to capture a larger share of the workforce pipeline, especially as regulatory changes in loan caps shift the financial dynamics of student financing. With the announced collaboration with a lending partner to address upcoming loan limit adjustments, the medical and veterinary schools can maintain affordability for students while sustaining tuition revenue, potentially offsetting the impact of higher interest rates on student debt.
The rebranding to Covista, coupled with a dedicated investor day, can elevate market perception by signaling a strategic focus on healthcare workforce development rather than generic for‑profit education. The narrative around “America’s largest healthcare educator” taps into a growing institutional demand for talent pipelines, especially from health systems that are exploring integrated training partnerships. This positioning could open revenue streams beyond tuition, such as consulting fees, curriculum licensing, and data analytics services to health systems seeking to align training with workforce needs. The brand transition may also mitigate regulatory scrutiny and negative stigma often associated with for‑profit institutions, improving the company’s ability to partner with public hospitals and non‑profit health systems. If investors interpret this shift positively, it could drive the share price toward a premium, especially if the company demonstrates accelerated enrollment conversion rates and higher fee‑intensity programs.
The company’s capital structure shows a net debt of $452 million against $504 million in adjusted EBITDA, yielding a net leverage ratio of roughly 0.9x, which is relatively low for a for‑profit educational entity. This strong balance sheet provides flexibility to pursue strategic acquisitions or expand capacity without incurring excessive interest expense, especially as interest rates rise. The company’s disciplined cash conversion rate—over $200 million in operating cash flow per year—provides ample runway for continued share repurchases and debt repayment, which can reinforce investor confidence and reduce the cost of capital. The consistent increase in operating cash flow, from $281 million in FY25 to $368 million in the most recent quarter, indicates that the company’s growth initiatives are translating into tangible cash generation, supporting long‑term sustainability.

The latest quarter shows an 8.4% core revenue increase when the one‑week academic calendar shift is excluded, suggesting that the underlying demand for healthcare education remains robust and is not a one‑off timing effect. Four distinct segments—Walden, Chamberlain, Medical and Veterinary—each contributed to revenue growth, but Walden alone delivered a 16.5% rise, driven by record enrollment in both health and non‑health programs. Walden’s operating leverage is evident in its adjusted EBITDA margin expanding from 28.4% to 39.8% after accounting for the calendar shift, reflecting efficient scaling of digital platforms and streamlined student support. The company’s ability to generate $428 million in trailing twelve‑month operating cash flow, up $146 million from the prior year, provides a strong buffer for future capital deployment and debt reduction, which can sustain the current share repurchase pace. The disciplined capital allocation plan, now authorizing $728 million remaining under a $750 million program, indicates management’s confidence in long‑term value creation and offers upside if market perception underestimates the company’s free cash flow generation. The forthcoming Investor Day is positioned as a catalyst; if the announced multi‑year capacity expansion and new revenue streams materialize as projected, it could shift the growth narrative toward a higher revenue guidance range and further justify the share repurchase activity. In addition, the rebrand to Covista, coupled with an explicit positioning as America’s largest healthcare educator, may unlock new strategic partnerships with health systems seeking comprehensive workforce solutions, potentially expanding the pipeline of graduate students beyond traditional modalities. Finally, the company’s philanthropic initiative, Covista Open Doors, aligns with the broader industry focus on workforce sustainability, reinforcing its brand equity among employers and potentially driving employer‑direct recruitment and program enrollment, which could translate into higher tuition revenues over the medium term.
The company’s enrollment trajectory—six consecutive quarters of growth—has recently accelerated in the Walden segment, with a 13% increase in total enrollment, indicating strong demand from working adults and career changers who benefit from flexible online modalities. Walden’s new programs in behavioral science and clinical psychology already attract over 1,000 students in less than a year, suggesting that program diversification is resonating with market needs and can create higher fee‑intensity opportunities. The addition of a PhD completion track for students who left their original program provides a unique, high‑margin product that can attract a niche segment willing to pay premium tuition, thereby enhancing the overall student revenue mix. Walden’s operating margin expansion of 29.4 basis points per quarter beyond the calendar shift illustrates that the company is capitalizing on cost efficiencies in content delivery and administrative overhead, thereby improving profitability even as enrollment scales. The company’s AI‑enabled learning pathways, announced as a focus area, can improve student outcomes and accelerate credential completion, thereby reducing time‑to‑degree and increasing revenue velocity. These digital capabilities also reduce the need for physical infrastructure, which aligns with the company’s capacity expansion strategy while keeping capital expenditures in check. As the healthcare workforce shortage deepens, the demand for accelerated and tech‑enabled pathways will likely increase, creating a favorable tailwind for the company’s enrollment and revenue growth prospects.
The medical and veterinary segment, while smaller, shows a healthy 6.9% revenue growth and a 17.6% increase in adjusted EBITDA, suggesting that the company is successfully leveraging its unique clinical partner network to attract students. The segment’s consistent operating margin around 30% demonstrates disciplined cost management, particularly in the utilization of AI for basic science curricula, which can lower faculty costs and improve pass rates for licensing exams. The company's partnership with the national health systems, highlighted in the news coverage, provides a pipeline of future students who may be recruited through employer‑direct agreements, thereby reducing marketing spend and improving enrollment conversion rates. The sector’s high alumni engagement, evidenced by 700 alumni in C‑suite roles and 300 chief nursing officers, can be leveraged for networking and placement opportunities that enhance the institution’s reputation, leading to a virtuous cycle of demand. The company’s focus on high‑volume programs—MD, nursing, veterinary—positions it to capture a larger share of the workforce pipeline, especially as regulatory changes in loan caps shift the financial dynamics of student financing. With the announced collaboration with a lending partner to address upcoming loan limit adjustments, the medical and veterinary schools can maintain affordability for students while sustaining tuition revenue, potentially offsetting the impact of higher interest rates on student debt.
The rebranding to Covista, coupled with a dedicated investor day, can elevate market perception by signaling a strategic focus on healthcare workforce development rather than generic for‑profit education. The narrative around “America’s largest healthcare educator” taps into a growing institutional demand for talent pipelines, especially from health systems that are exploring integrated training partnerships. This positioning could open revenue streams beyond tuition, such as consulting fees, curriculum licensing, and data analytics services to health systems seeking to align training with workforce needs. The brand transition may also mitigate regulatory scrutiny and negative stigma often associated with for‑profit institutions, improving the company’s ability to partner with public hospitals and non‑profit health systems. If investors interpret this shift positively, it could drive the share price toward a premium, especially if the company demonstrates accelerated enrollment conversion rates and higher fee‑intensity programs.
The company’s capital structure shows a net debt of $452 million against $504 million in adjusted EBITDA, yielding a net leverage ratio of roughly 0.9x, which is relatively low for a for‑profit educational entity. This strong balance sheet provides flexibility to pursue strategic acquisitions or expand capacity without incurring excessive interest expense, especially as interest rates rise. The company’s disciplined cash conversion rate—over $200 million in operating cash flow per year—provides ample runway for continued share repurchases and debt repayment, which can reinforce investor confidence and reduce the cost of capital. The consistent increase in operating cash flow, from $281 million in FY25 to $368 million in the most recent quarter, indicates that the company’s growth initiatives are translating into tangible cash generation, supporting long‑term sustainability.

Bear case

The company’s reliance on external lending partners, such as the proposed partnership with a major borrower, introduces a significant regulatory risk. The upcoming loan cap changes, which the company has only partially addressed, could reduce the amount of student debt available, potentially lowering tuition revenue if students are unable to finance their education. Management’s limited progress on securing definitive documentation for this partnership signals uncertainty that could impede enrollment growth, especially in the medical and veterinary segments where loan funding is a critical component of the student financing model.

Consolidation Items Breakdown of Revenue (2025)

Breakdown of Revenue (2025)

Peer comparison

Companies in the Education & Training Services

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	GHC	Graham Holdings Co	20.16 Bn	15.79	4.11	880.76 Mn
2	LOPE	Grand Canyon Education, Inc.	9.28 Bn	22.13	8.39	-
3	LAUR	Laureate Education, Inc.	4.80 Bn	17.51	2.82	127.71 Mn
4	LRN	Stride, Inc.	4.41 Bn	12.10	1.75	417.18 Mn
5	PRDO	PERDOCEO EDUCATION Corp	3.46 Bn	15.14	4.09	-
6	UTI	Universal Technical Institute Inc	2.01 Bn	36.95	2.35	101.42 Mn
7	STRA	Strategic Education, Inc.	1.92 Bn	15.02	1.51	-
8	LINC	Lincoln Educational Services Corp	1.32 Bn	65.13	2.54	-

Research Tools

Covista Inc. (NYSE: ATGE)

About

Investment thesis

Bull case

Bear case

Consolidation Items Breakdown of Revenue (2025)

Breakdown of Revenue (2025)

Peer comparison

Research Tools

Covista Inc. (NYSE: ATGE)

About

Investment thesis

Bull case

Bear case

Consolidation Items Breakdown of Revenue (2025)

Breakdown of Revenue (2025)

Peer comparison

Create an account

Sign In

Reset Password